Skip to content
Open access

Deep learning driven lung cancer prediction using modified u-net segmentation and CNN classification

Oct 2026 · Egyptian Journal of Bronchology · Vol 20 · 0 citations · 21 references

Abstract

Lung cancer remains a major contributor to global cancer mortality, highlighting the urgent need for accurate and efficient early diagnostic tools. This study proposes a deep learning–based computer-aided diagnosis (CAD) framework for automated lung nodule segmentation and malignancy classification using the publicly available LIDC-IDRI CT dataset. The framework combines a modified U-Net segmentation network a residual (ResNet-34) encoder, attention gates at the skip connections, and an Atrous Spatial Pyramid Pooling (ASPP) module for multi-scale feature fusion with a custom Squeeze-and-Excitation (SE) CNN classifier, trained using a two-stage optimisation strategy. On a held-out, patient-level test split, the segmentation network achieved a Dice score of 0.847 (IoU 0.736), and the classification network achieved a mean accuracy of 94.5% (± 0.3% SD across five training runs; 95% CI ≈ 94.2–94.8%), with sensitivity of 92.3%, specificity of 96.1%, and AUC-ROC of 0.967, outperforming ResNet-50, VGG-16, and DenseNet-121 baselines trained under an identical protocol. These results are competitive with, and in several respects exceed, recently reported approaches on the same dataset, although a transformer-based segmentation model achieved a marginally higher Dice score at substantially greater computational cost. The framework was evaluated on a single, retrospective, single-institution dataset; prospective, multi-institutional validation, together with an assessment of end-to-end deployment latency, is required before any claim of clinical readiness can be made. These findings indicate the potential of the proposed CAD framework to support radiologists as a second-reader tool in lung cancer screening, pending further external validation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.